⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACXP News
Acurx Pharmaceuticals, Inc. Common Stock
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
prnewswire.com
ACXP
New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP)
accessnewswire.com
NTHI
CISO
NRXP
SNYR
DVLT
ACXP
AERT
New to The Street Show #702 Airs Today on Bloomberg at 6:30 PM EST
accessnewswire.com
RDZN
NRXP
AERT
CISO
ACXP
New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television
accessnewswire.com
DVLT
ACXP
Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
prnewswire.com
ACXP
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens
prnewswire.com
ACXP
Acurx Announces New Data on its DNA pol IIIC Inhibitor Antibiotics Demonstrating a Potential Class Effect of Gut Microbiome Selectivity Presented at IDWeek 2025 Scientific Conference
prnewswire.com
ACXP
Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update
prnewswire.com
ACXP
New to The Street to Broadcast Nationwide on Bloomberg TV Tonight at 6:30 PM EST Featuring Roadzen, Spartan Equipment, XION, Metaterra, and YY Group
accessnewswire.com
LASE
AERT
ACXP
DVLT
YYGH
Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC
accessnewswire.com
SNYR
DVLT
ACXP
RDZN
AREB
MUSQ
NTHI